Efficacy of Autologous Bone Marrow–Derived Stem Cell Transplantation in Patients With Type 2 Diabetes MellitusAnil Bhansali, Santosh Ramakrishnan, Vimal Upreti et al.|Stem Cells and Development|2009Cited by 131
Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative StudyShobhit Bhansali, Anil Bhansali, Pinaki Dutta et al.|Stem Cells and Development|2016Cited by 123
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axisKarthik Narayanan, R. K. Marwaha, Deepak Bansal et al.|Pediatric Blood & Cancer|2013Cited by 85
Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivityShobhit Bhansali, Anil Bhansali, Pinaki Dutta et al.|Diabetology & Metabolic Syndrome|2017Cited by 21
Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemiaRama Walia, Deepak Bansal, Anuradha Aggarwal et al.|Pediatric Hematology and Oncology|2019Cited by 19